about
Non-A, non-B hepatitis.Hepatitis C virus. A review.The elusive hepatitis C virusHepatitis C virus infection in Iceland: a recently introduced blood-borne diseaseDiverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donorsImmunodominant regions within the hepatitis C virus core and putative matrix proteinsDetection of antibodies to hepatitis C virus in U.S. blood donorsHepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.Incidence, prevalence, and clinical course of hepatitis C following liver transplantation.Hepatitis C: virology, epidemiology, clinical course, and treatment.Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major.Prevalence of anti-HCV among Chinese patients with acute and chronic liver disease.Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia.Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India.Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysis.Prevalence of chronic liver diseases and anti-HCV antibodies in different districts of Saga, Japan.Antibodies to hepatitic C virus and chronic liver disease among Finnish patients with haemophilia.High level of hepatitis C endemicity in Gabon, equatorial Africa.High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area.Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000.Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma.Prevalence of hepatitis C virus antibody in an area endemic for hepatitis B virus and human T cell leukaemia virus.
P2860
Q27469293-336F5437-DD61-4621-BABD-83EDC6F0E873Q27469295-88169F1C-9224-46F1-92B3-B7D544B54349Q27478191-7948D738-5D37-4F5D-8807-304865A5AC65Q27485597-72266483-DC12-42A0-AC21-7C1D00750A5CQ27485762-B43D0321-8E21-4F85-9753-E082BFBAD08FQ27488203-424D12D5-E462-4E4B-8D85-345AD287D8ECQ27488778-6812CEB5-975C-454B-947A-95E870B0D350Q33936043-72EFB90F-8E37-4073-8921-92D8747A0BECQ33954084-33E554D5-E0EB-4E21-8E56-7035A19F1230Q34300905-6B814304-8F31-45E0-8F2A-3ABD9FC2D3B2Q35233238-08EC42DA-DA9B-466F-AA91-507149A690D4Q37262369-64881BFA-96CB-47E0-933C-78C3D6978091Q42981238-F74D43B2-A952-4B98-A820-34FDFB3A2BADQ42981412-5FF588BD-EDDC-4B93-AA21-E54EB0EC39FDQ42981526-F20AB7FC-31A6-4A2D-BC10-6F6DFCF9888BQ42981825-D89F9A36-CFA5-4085-9B2A-3BBFA56A83F7Q42983311-199C83CD-F53C-41B6-AEE5-4165A4CF2CACQ42984197-4F1979BE-1602-44C0-9454-ACCEB868C856Q42986929-D649FC0E-CA9D-41E9-ABC1-FDE815A35818Q43035375-49B4B05D-250C-48F1-9E5B-8E4E5324A296Q43049198-FE95AA51-927B-454A-9C78-6A1E479ABD7BQ43795768-782DB7C8-3EBD-4796-9D91-57B0F8817BAEQ45850898-9FE805D2-9FEC-48A1-829D-40B9F0904315Q45860436-F2ABD879-E2C4-4D93-BBFB-BEE0C237B6C9
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Antibody to hepatitis C virus in German blood donors.
@en
Antibody to hepatitis C virus in German blood donors.
@nl
type
label
Antibody to hepatitis C virus in German blood donors.
@en
Antibody to hepatitis C virus in German blood donors.
@nl
prefLabel
Antibody to hepatitis C virus in German blood donors.
@en
Antibody to hepatitis C virus in German blood donors.
@nl
P2093
P1433
P1476
Antibody to hepatitis C virus in German blood donors.
@en
P2093
P356
10.1016/S0140-6736(89)90500-X
P407
P577
1989-08-01T00:00:00Z